Pharmacokinetics and pharmacodynamics of infliximab in a phase III trial in patients with plaque-type psoriasis

被引：0
|
作者：
Zhu, Y
Menter, A
Jang, H
Zhou, H
机构：
[1] Centocor Inc, Malvern, PA 19355 USA
[2] Baylor Univ, Med Ctr, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB222 / AB222
页数：1
相关论文
共 50 条
  • [21] Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial
    David, Michael
    Gospodinov, Dimitar Konstantinov
    Gheorghe, Nicola
    Mateev, Grisha Stefanov
    Rusinova, MariyanaVenelinova
    Hristakieva, Evgeniya
    Solovastru, Laura Gheuca
    Patel, Rita. V.
    Giurcaneanu, Calin
    Hitova, Mariela Chepileva
    Purcaru, Anca Ioana
    Horia, Beti
    Tsingov, Iliya Iliev
    Yankova, Rumyana Kaloferova
    Kadurina, Miroslava Ilieva
    Ramon, Michael
    Rotaru, Maria
    Simionescu, Olga
    Benea, Vasile
    Demerdjieva, Zdravka Velichkova
    Cosgarea, Maria Rodica
    Morariu, Horia Silviu
    Michael, Ziv
    Cristodor, Patricia
    Nica, Carmen
    Silverman, Michael H.
    Bristol, David R.
    Harpaz, Zivit
    Farbstein, Motti
    Cohen, Shira
    Fishman, Pnina
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 931 - 938
  • [22] Barrier repair in chronic plaque-type psoriasis
    Goon, ATJ
    Yosipovitch, G
    Chan, YH
    Goh, CL
    SKIN RESEARCH AND TECHNOLOGY, 2004, 10 (01) : 10 - 13
  • [23] Alcohol as a risk factor for plaque-type psoriasis
    Behnam, SM
    Behnam, SE
    Koo, JY
    CUTIS, 2005, 76 (03): : 181 - 185
  • [24] Oral R115866 in patients with moderate to severe plaque-type psoriasis: Safety evaluation from a phase IIA trial
    van de Kerkhof, P
    Mertens, J
    Steijlen, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB205 - AB205
  • [25] SorafenibGeneralised plaque-type psoriasis: case report
    Reactions Weekly, 2022, 1934 (1) : 387 - 387
  • [26] Is tonsillectomy a therapeutic option for plaque-type psoriasis?
    Yamamoto, Toshiyuki
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (04) : E153 - E153
  • [27] CYCLOSPORINE FOR PLAQUE-TYPE PSORIASIS - RESULTS OF A MULTIDOSE, DOUBLE-BLIND TRIAL
    ELLIS, CN
    FRADIN, MS
    MESSANA, JM
    BROWN, MD
    SIEGEL, MT
    HARTLEY, AH
    ROCHER, LL
    WHEELER, S
    HAMILTON, TA
    PARISH, TG
    ELLISMADU, M
    DUELL, E
    ANNESLEY, TM
    COOPER, KD
    VOORHEES, JJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (05): : 277 - 284
  • [28] Fatigue in patients with plaque-type psoriasis: lack of an association with plasma cytokines
    Skoie, Inger Marie
    Dalen, Ingvild
    Kvivik, Ingeborg
    Bardsen, Kjetil
    Omdal, Roald
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (01) : 16 - 23
  • [29] Infliximab in the treatment of plaque type psoriasis
    Saraceno, Rosita
    Saggini, Andrea
    Pietroleonardo, Lucia
    Chimenti, Sergio
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2009, 2 : 27 - 37
  • [30] Fatigue in patients with plaque-type psoriasis: lack of an association with plasma cytokines
    Inger Marie Skoie
    Ingvild Dalen
    Ingeborg Kvivik
    Kjetil Bårdsen
    Roald Omdal
    European Journal of Dermatology, 2020, 30 : 16 - 23
12345